X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1339) 1339
Publication (85) 85
Book Chapter (13) 13
Book Review (9) 9
Dissertation (4) 4
Conference Proceeding (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
levosimendan (1246) 1246
humans (577) 577
index medicus (515) 515
cardiac & cardiovascular systems (400) 400
male (380) 380
heart failure (366) 366
female (302) 302
pyridazines - therapeutic use (302) 302
dobutamine (301) 301
hydrazones - therapeutic use (300) 300
cardiotonic agents - therapeutic use (272) 272
animals (252) 252
heart failure - drug therapy (238) 238
pharmacology & pharmacy (232) 232
pyridazines - pharmacology (232) 232
hydrazones - pharmacology (225) 225
calcium sensitizer (199) 199
middle aged (192) 192
mortality (185) 185
aged (181) 181
heart-failure (169) 169
anesthesiology (166) 166
cardiotonic agents - pharmacology (165) 165
treatment outcome (160) 160
pyridazines - administration & dosage (158) 158
hydrazones - administration & dosage (157) 157
cardiotonic agents - administration & dosage (141) 141
surgery (128) 128
intravenous levosimendan (120) 120
milrinone (119) 119
cardiac surgery (118) 118
critical care medicine (118) 118
safety (114) 114
heart failure - physiopathology (112) 112
efficacy (111) 111
cardiopulmonary bypass (107) 107
heart (106) 106
hemodynamics - drug effects (104) 104
medicine & public health (101) 101
rats (95) 95
simendan (95) 95
cardiac patients (92) 92
infusions, intravenous (92) 92
care and treatment (89) 89
adult (86) 86
myocardial contraction - drug effects (86) 86
cardiology (83) 83
dose-response relationship, drug (83) 83
trial (83) 83
cardiovascular (80) 80
cardiac troponin-c (79) 79
hemodynamics (78) 78
acute heart failure (77) 77
cardiogenic shock (76) 76
analysis (75) 75
respiratory system (75) 75
septic shock (75) 75
time factors (75) 75
acute myocardial-infarction (74) 74
peripheral vascular disease (74) 74
echocardiography (73) 73
acute disease (72) 72
vasodilator agents - therapeutic use (70) 70
health aspects (68) 68
medicine, general & internal (68) 68
sepsis (66) 66
cardiotonic agents - adverse effects (65) 65
management (65) 65
prospective studies (65) 65
dysfunction (64) 64
pyridazines - adverse effects (64) 64
guinea-pig heart (63) 63
hydrazones - adverse effects (63) 63
inotropes (61) 61
inotropic agents (61) 61
calcium - metabolism (60) 60
research (60) 60
drug therapy (59) 59
dobutamine - therapeutic use (58) 58
vasodilator agents - pharmacology (57) 57
double-blind method (56) 56
infusion (56) 56
failure (55) 55
cardiac-surgery (53) 53
metaanalysis (53) 53
troponin-c (53) 53
calcium (52) 52
heart failure - mortality (52) 52
pediatrics (52) 52
randomized controlled trials as topic (52) 52
rats, wistar (52) 52
ventricular function, left - drug effects (52) 52
blood pressure - drug effects (51) 51
ca2+ sensitizer (51) 51
congestive-heart-failure (51) 51
calcium sensitizer levosimendan (50) 50
continuous-infusion (49) 49
coronary artery bypass (49) 49
heart rate - drug effects (49) 49
abridged index medicus (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1168) 1168
German (58) 58
Spanish (40) 40
Portuguese (19) 19
Russian (16) 16
Czech (14) 14
French (12) 12
Turkish (12) 12
Chinese (4) 4
Italian (3) 3
Hungarian (2) 2
Japanese (2) 2
Polish (2) 2
Slovak (2) 2
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 11/2017, Volume 377, Issue 19, pp. 1899 - 1900
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 11/2017, Volume 377, Issue 19, pp. 1900 - 1901
Journal Article
American Journal of Physiology: Heart and Circulatory Physiology, ISSN 0363-6135, 01/2002, Volume 282, Issue 1, pp. H131 - H137
Levosimendan has been reported to increase cardiac Ca super(2+) sensitivity, thereby not enhancing intracellular Ca super(2+) or diastolic tension. This may be... 
levosimendan
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 01/2018, Volume 251, pp. 22 - 31
Journal Article
ASAIO Journal, ISSN 1058-2916, 11/2013, Volume 59, Issue 6, pp. 554 - 557
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) provides temporary mechanical circulatory support in patients with refractory cardiogenic shock,... 
ECMO | levosimendan | heart failure
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 11/2017, Volume 377, Issue 19, pp. 1899 - 1899
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 10/2001, Volume 428, Issue 3, pp. 311 - 314
Levosimendan, a new inodilator developed for the treatment of heart failure has been shown to have a vasodilatory effect via opening of K channels in the... 
Mitochondrion | channel opener | Levosimendan
Journal Article
Acta Medica Mediterranea, ISSN 0393-6384, 2019, Volume 35, Issue 2, pp. 1103 - 1107
Journal Article
Lancet, The, ISSN 0140-6736, 01/2013, Volume 381, Issue 9860, pp. 29 - 39
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2017, Volume 243, pp. 389 - 395
Journal Article
Toxicology Reports, ISSN 2214-7500, 2019, Volume 6, pp. 232 - 238
We investigated the effect of levosimendan on cisplatin (Cis)-induced nephrotoxicity. Rats were divided into four groups (n = 6). The first and second groups... 
Inodilator | Levosimendan | Nephrotoxicity | Anti-inflammatory | Cisplatin
Journal Article
EMERGENCY MEDICINE JOURNAL, ISSN 1472-0205, 12/2013, Volume 30, Issue 12, pp. 1060 - 1060
A short-cut review was carried out to establish whether levosimendan improves outcome in cases of cardiogenic shock. Five studies were directly relevant to the... 
EMERGENCY MEDICINE | LEVOSIMENDAN | CARDIOGENIC-SHOCK
Journal Article
Journal of International Medical Research, ISSN 0300-0605, 8/2019, Volume 47, Issue 8, pp. 3502 - 3512
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.